CN Patent

CN105452213B — 富马酸酯前体药物及其在治疗多种疾病中的应用

Assigned to Alkermes Pharma Ireland Ltd · Expires 2017-09-22 · 9y expired

What this patent protects

本发明提供了式(I)化合物，及其药物组合物。

USPTO Abstract

本发明提供了式(I)化合物，及其药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN105452213B
Jurisdiction
CN
Classification
—
Expires
2017-09-22
Drug substance claim
No
Drug product claim
No
Assignee
Alkermes Pharma Ireland Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.